Company · CIK 0001357874 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
PRECISION BIOSCIENCES INC · DTIL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 AForm 4 → | Jun 5, 7:39 am EDT | Melinda BrownDirector | 20,979 | — | — | 20,979 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 7:38 am EDT | Stanley FrankelDirector | 20,979 | — | — | 20,979 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 7:37 am EDT | Geno J GermanoDirector | 20,979 | — | — | 20,979 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 7:36 am EDT | Shari Lisa PireDirector | 20,979 | — | — | 20,979 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 7:35 am EDT | Kevin BuehlerDirector | 20,979 | — | — | 20,979 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 4:06 pm EDT | J. Jefferson SmithChief Research Officer | 57,389 | — | — | 57,389 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 4:06 pm EDT | Dario ScimecaGeneral Counsel and Secretary | 107,604 | — | — | 107,604 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 4:05 pm EDT | John Alexander KellyChief Financial Officer | 193,688 | — | — | 193,688 | — | |
| Jun 1, 2026 AForm 4 → | Jun 3, 4:05 pm EDT | Michael AmorosoPresident and CEO, Director | 573,888 | — | — | 573,888 | — |